- Home/
- Article /
- Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials.
Full Author : ['Sharma, Ashish', 'Kumar, Nilesh', 'Parachuri, Nikulaa', 'Karanam, Dhatri', 'Kuppermann, Baruch D', 'Bandello, Francesco', 'Regillo, Carl D']
Journal Title : Eye (London, England)
Chapter : Section3
Journal Year : 2022
Cited by : Not Available
.....
Keywords : ["personalized treatment interval pti regime", "faricimab phase dme trial significance", "future dme trial"]